Results 41 to 50 of about 1,626 (189)

CYP2D6 genotype and associated 5-HT₃ receptor antagonist outcomes: A systematic review and meta-analysis. [PDF]

Clin Transl Sci
Abstract 5‐hydroxytryptamine‐3 (5‐HT3) receptor antagonists including ondansetron, tropisetron, dolasetron, palonosetron, granisetron, and ramosetron are commonly used to prevent and treat nausea and vomiting. Most of these medications are at least partially metabolized via the highly polymorphic CYP2D6 enzyme, resulting in variations of metabolism ...
Moore C, Williams E, Dyas R, Halman A, Stenta T, Khatri D, Elliott DA, Lange PW, Caudle KE, Conyers R.   +9 more
europepmc   +2 more sources

Comparison of ramosetron plus dexamethasone with ramosetron alone in the prevention of nausea and vomiting after gynecologic laparoscopic surgery

Korean Journal of Anesthesiology, 2009
Postoperative nausea and vomiting (PONV) is extremely distressing and uncomfortable, and is noted frequently in patients who have undergone gynecologic laparoscopic surgery. In this study, we compared the efficacy of a combination of ramosetron plus dexamethasone and ramosetron alone in reducing of PONV after gynecologic laparoscopic surgery.Sixty ...
Dae Seok, Oh, Jeong Han, Lee, Sang Eun, Lee, Young Hwan, Kim, Se Hun, Lim, Kun Moo, Lee, Soon Ho, Cheong, Young Kyun, Choe, Young Jae, Kim, Chee Mahn, Shin   +9 more
openaire   +2 more sources

The effectiveness of ramosetron and ondansetron for preventing postoperative nausea and vomiting after arthroscopic rotator cuff repair: a randomized controlled trial

Journal of Orthopaedic Surgery and Research, 2020
Background Arthroscopic rotator cuff repair is a painful procedure, and treatment of emetic events associated with drugs used in the current multimodal pain management remains challenging.
Sang-Uk Lee, Hyo-Jin Lee, Yang-Soo Kim
doaj   +1 more source

Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

, 2022
Patients with quiescent inflammatory bowel disease (IBD) frequently suffer diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms, such as abdominal pain or stool irregularities. Here, we assessed the effect of ramosetron, a serotonin type 3
Mori, Sumire, Oshima, Tadayuki, Hirokazu Fukui, Toshihiko Tomita, Daisuke Morishita, Morishita, Daisuke, Miwa, Hiroto, Sumire Mori, Tadayuki Oshima, Shinzaki, Shinichiro, Fukui, Hirokazu, Tomita, Toshihiko, Hiroto Miwa, Shinichiro Shinzaki   +13 more
core   +1 more source

Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis.

PLoS ONE, 2017
BackgroundPostoperative nausea and vomiting is a distressing complication of surgery, and 5-HT3 receptor antagonists are often prescribed to prevent it.
Ayako Yokoi, Takahiro Mihara, Koui Ka, Takahisa Goto   +3 more
doaj   +1 more source

Comparison of ramosetron and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials

Journal of International Medical Research, 2019
Objective We conducted a systematic literature search and meta-analysis to identify randomized controlled trials (RCTs) comparing the efficacy and safety of ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting (PONV; PON ...
Yiping Li, Ruiming Deng, Juan Zhou, Yuan Chen, Aiping Ouyang   +4 more
doaj   +1 more source

Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct [PDF]

Korean Journal of Anesthesiology, 2012
BackgroundDespite the development of a new class of antiemetics, postoperative nausea and vomiting (PONV) still remains a frequent and distressing complication.
Yong Seon Choi, Jae-Kwang Shim, Seung-Ho Ahn, Young Lan Kwak   +3 more
doaj   +1 more source

Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study [PDF]

Korean Journal of Anesthesiology, 2013
BackgroundPostoperative nausea and vomiting (PONV) continues to be a major problem, because PONV is associated with delayed recovery and prolonged hospital stay.
Sung-Hoon Kim, Jeong-Yeon Hong, Won Oak Kim, Hae Keum Kil, Myong-Hwan Karm, Jai-Hyun Hwang   +5 more
doaj   +1 more source

Ramosetron for the prevention of cisplatin-induced acute emesis: A prospective randomized comparison with granisetron

, 2002
Control of nausea and vomiting is very important in determining patient compliance with cisplatin chemotherapy. A multicentre, randomized, single-blind study was conducted to compare the tolerability and efficacy of ramosetron with those of granisetron ...
Lee, JA, Bang, YJ, Park, YS, Kim, WK, Yoon, HJ, Kim, HC, Lee, KH, Cho, KS, Cho, EK, Lim, HY, Lee, JC, Kim, NK, Shin, DB, Park, YH, Kang, YK, Kim, TY, Kim, SY, Ryoo, BY, Lee, KS, Heo, DS   +19 more
core   +1 more source

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine

, 2011
BACKGROUND: The 5-HT(3) receptor antagonists are known to be effective for the treatment of diarrhea-predominant irritable bowel syndrome (IBS), but not widely used yet. The aim of this study was to compare the efficacy and safety of ramosetron, a 5-HT(3)
H. J. Park, Rhee, PL, K. J. Lee, S. J. Myung, Y. T. Bak, N. Y. Kim, S. C. Choi, Choi, MK, O. Y. Lee, C. I. Sohn, Huh, KC, P. L. Rhee, Kim, NY, Park, HJ, Lee, OY, Myung, SJ, Choi, SC, M. K. Choi, Bak, YT, J. K. Kwon, Lee, KJ, Kwon, JK, Sohn, CI, K. C. Huh, J. S. Lee, Lee, JS, 박효진, ���������   +27 more
core   +2 more sources